BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24213107)

  • 1. DNA Methylation and the HOXC6 Paradox in Prostate Cancer.
    Vinarskaja A; Yamanaka M; Ingenwerth M; Schulz WA
    Cancers (Basel); 2011 Sep; 3(4):3714-25. PubMed ID: 24213107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.
    Veeck J; Wild PJ; Fuchs T; Schüffler PJ; Hartmann A; Knüchel R; Dahl E
    BMC Cancer; 2009 Jul; 9():217. PubMed ID: 19570204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer.
    McCabe CD; Spyropoulos DD; Martin D; Moreno CS
    Cancer Res; 2008 Mar; 68(6):1988-96. PubMed ID: 18339881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of HOXC6 expression induces apoptosis in prostate cancer cells.
    Ramachandran S; Liu P; Young AN; Yin-Goen Q; Lim SD; Laycock N; Amin MB; Carney JK; Marshall FF; Petros JA; Moreno CS
    Oncogene; 2005 Jan; 24(1):188-98. PubMed ID: 15637592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of HOXC6 in prostate cancer development.
    Hamid AR; Hoogland AM; Smit F; Jannink S; van Rijt-van de Westerlo C; Jansen CF; van Leenders GJ; Verhaegh GW; Schalken JA
    Prostate; 2015 Dec; 75(16):1868-76. PubMed ID: 26310814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-β signaling pathway.
    Chen L; Sun DZ; Fu YG; Yang PZ; Lv HQ; Gao Y; Zhang XY
    Cell Signal; 2020 Feb; 66():109444. PubMed ID: 31629025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide analysis of HOXC4 and HOXC6 regulated genes and binding sites in prostate cancer cells.
    Luo Z; Farnham PJ
    PLoS One; 2020; 15(2):e0228590. PubMed ID: 32012197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and transcriptional activation of the promoter for the neural cell adhesion molecule by HoxC6 (Hox-3.3).
    Jones FS; Holst BD; Minowa O; De Robertis EM; Edelman GM
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6557-61. PubMed ID: 8393570
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zhou J; Yang X; Song P; Wang H; Wang X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2715-2720. PubMed ID: 31271305
    [No Abstract]   [Full Text] [Related]  

  • 11. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
    Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
    Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
    Kaur P; Mani S; Cros MP; Scoazec JY; Chemin I; Hainaut P; Herceg Z
    Tumour Biol; 2012 Apr; 33(2):325-36. PubMed ID: 22351518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
    Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
    Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer.
    Hussain I; Bhan A; Ansari KI; Deb P; Bobzean SA; Perrotti LI; Mandal SS
    Biochim Biophys Acta; 2015 Jun; 1849(6):697-708. PubMed ID: 25725483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence.
    Lambiv WL; Vassallo I; Delorenzi M; Shay T; Diserens AC; Misra A; Feuerstein B; Murat A; Migliavacca E; Hamou MF; Sciuscio D; Burger R; Domany E; Stupp R; Hegi ME
    Neuro Oncol; 2011 Jul; 13(7):736-47. PubMed ID: 21642372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of an imprinted gene network in prostate cancer.
    Ribarska T; Goering W; Droop J; Bastian KM; Ingenwerth M; Schulz WA
    Epigenetics; 2014 May; 9(5):704-17. PubMed ID: 24513574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Mediated Reactivation of DKK3 Expression Attenuates TGF-β Signaling in Prostate Cancer.
    Kardooni H; Gonzalez-Gualda E; Stylianakis E; Saffaran S; Waxman J; Kypta RM
    Cancers (Basel); 2018 May; 10(6):. PubMed ID: 29843383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Dis; 2011 Nov; 17(8):794-800. PubMed ID: 21819494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated Hoxc6 expression is associated with poor survival in gastric cancer patients.
    Zhang Q; Jin XS; Yang ZY; Wei M; Liu BY; Gu QL
    Neoplasma; 2013; 60(4):439-45. PubMed ID: 23581417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.